Adenocarcinoma of the Breast
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Breast.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma [Phase 2]
Phase 2 trial assessing IMP321 (eftilagimod alpha) as an adjunct to paclitaxel in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility [NA]
Feasibility results from a completed trial evaluating a dose-dense sequence of epirubicin and cyclophosphamide followed by paclitaxel in bre…